In vitro interaction between human immunodeficiency virus type 1 rev protein and splicing factor ASF/SF2-associated protein, p32

被引:74
作者
Tange, TO [1 ]
Jensen, TH [1 ]
Kjems, J [1 ]
机构
[1] AARHUS UNIV,DEPT MOLEC BIOL,DK-8000 AARHUS C,DENMARK
关键词
D O I
10.1074/jbc.271.17.10066
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Continuous replication of human immunodeficiency virus type 1 requires the expression of the regulatory protein Rev, which binds to the Rev response element (RRE) and up-regulates the cytoplasmic appearance of singly spliced and unspliced mRNA species. It has been demonstrated that the murine protein YL2 interacts with Rev in vivo and modulates the activity of Rev (Luo, Y., Yu, H., and Peterlin, B. M. (1994) J. Virol. 68, 3850-3856). Here we show that the YL2 human homologue, the p32 protein, which co-purifies with alternative splicing factor ASF/SF2, interacts directly with the basic domain of Rev in vitro and that the Rev-p32 complex is resistant to high concentrations of salt or nonionic detergent. Protein footprinting data suggest that Rev interacts specifically with amino acids within the 196-208 region of p32. An analysis of the ternary complex, formed among p32, Rev, and RRE RNA, shows that Rev can bridge the association of p32 and RRE. Furthermore, we demonstrate that exogenously added p32 specifically relieves the inhibition of splicing in vitro exerted by the basic domain of Rev. Our data are consistent with a model in which p32 functions as a link between Rev and the cellular splicing apparatus.
引用
收藏
页码:10066 / 10072
页数:7
相关论文
共 46 条
[11]  
HAMMARSKJOLD ML, 1994, J VIROL, V68, P951
[12]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REGULATOR OF VIRION EXPRESSION, REV, FORMS NUCLEOPROTEIN FILAMENTS AFTER BINDING TO A PURINE-RICH BUBBLE LOCATED WITHIN THE REV-RESPONSIVE REGION OF VIRAL MESSENGER-RNAS [J].
HEAPHY, S ;
FINCH, JT ;
GAIT, MJ ;
KARN, J ;
SINGH, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (16) :7366-7370
[13]   CLONING AND EXPRESSION OF A CDNA COVERING THE COMPLETE CODING REGION OF THE P-32 SUBUNIT OF HUMAN PRE-MESSENGER-RNA SPLICING FACTOR-SF2 [J].
HONORE, B ;
MADSEN, P ;
RASMUSSEN, HH ;
VANDEKERCKHOVE, J ;
CELIS, JE ;
LEFFERS, H .
GENE, 1993, 134 (02) :283-287
[14]   STEROID-RECEPTOR FUSION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REV TRANSACTIVATOR - MAPPING CRYPTIC FUNCTIONS OF THE ARGININE-RICH MOTIF [J].
HOPE, TJ ;
HUANG, XJ ;
MCDONALD, D ;
PARSLOW, TG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (19) :7787-7791
[15]   TRANSDOMINANT INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REV OCCURS THROUGH FORMATION OF INACTIVE PROTEIN COMPLEXES [J].
HOPE, TJ ;
KLEIN, NP ;
ELDER, ME ;
PARSLOW, TG .
JOURNAL OF VIROLOGY, 1992, 66 (04) :1849-1855
[16]  
HUANG ZM, 1995, MOL CELL BIOL, V15, P3864
[17]  
Jeang K T, 1991, AIDS, V5 Suppl 2, pS3, DOI 10.1097/00002030-199101001-00002
[18]   TOOLS FOR THE PRODUCTION AND PURIFICATION OF FULL-LENGTH, N-TERMINAL OR C-TERMINAL P-32 LABELED PROTEIN, APPLIED TO HIV-1 GAG AND REV [J].
JENSEN, TH ;
JENSEN, A ;
KJEMS, J .
GENE, 1995, 162 (02) :235-237
[19]   INTERMOLECULAR BINDING-SITES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REV PROTEIN DETERMINED BY PROTEIN FOOTPRINTING [J].
JENSEN, TH ;
LEFFERS, H ;
KJEMS, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (23) :13777-13784
[20]   THE BASIC DOMAIN OF REV FROM HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SPECIFICALLY BLOCKS THE ENTRY OF U4/U6 U5 SMALL NUCLEAR RIBONUCLEOPROTEIN IN SPLICEOSOME ASSEMBLY [J].
KJEMS, J ;
SHARP, PA .
JOURNAL OF VIROLOGY, 1993, 67 (08) :4769-4776